stock-detail (CTIC)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

CDC Endorses A More Effective HPV Vaccine To Prevent Cancer

2/2/2016 12:00 pm

(NPR/Shots blog) Feb 1, 2016 - The updated childhood immunization schedule, released today from the Centers for Disease Control and Prevention, includes a couple tweaks to vaccine recommendations for older children and teens.

Genetic Chaos In Tumours Could Help Predict Chemo Response

8/4/2015 11:02 am

(Cancer Research UK) Aug 4, 2015 - Francis Crick Institute and UCL Cancer Institute scientists, funded by Cancer Research UK, the Academy of Medical Sciences and the National Institute for Health Research, have shown how the level of genetic chaos in tumours could help predict patients’ response to chemotherapy according to research published in Cancer Discovery.

Potential New Therapy Approaches To Reverse Kidney Damage Identified

8/4/2015 11:02 am

(MD Anderson) Aug 3, 2015 - Study shows that cell plasticity program resulting from kidney damage can be targeted to reverse disease and fibrosis.

MD Anderson Study Reveals New Insight Into DNA Repair

8/4/2015 11:02 am

(MD Anderson) Aug 3, 2015 - DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy.

New Cancer Plan Could Save Thousands

7/20/2015 11:04 am

(PharmaTimes [UK]) July 20, 2015 - An Independent Cancer Taskforce has outlined six priority areas to help the National Health Service improve cancer outcomes in England in a new strategy, which could save and extend thousands of lives.

Living With Cancer: Curses and Blessings

7/17/2015 11:03 am

(New York Times/Well blog) July 16, 2015 - Like someone with bipolar disorder, I see-saw between irritability and elation, depression and euphoria.

Simple Test May Help Predict the Need for Repeat Colonoscopy

7/7/2015 11:05 am

(Medscape Medical News) July 6, 2015 - A simple panel of genetic biomarkers may be able to predict which individuals are at high and low risk of developing colorectal cancer following screening colonoscopy, and therefore could identify those who should have repeat screening, say a team of researchers from Luxembourg.

Agios Pharmaceuticals Announces FDA Orphan Drug Designation Granted to AG-120 for Treatment of IDH1-Mutant Positive Acute Myelogenous Leukemia

6/11/2015 11:05 am

(MarketWatch) June 10, 2015 - Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for AG-120 for treatment of patients with acute myelogenous leukemia (AML).

Women Four Times Less Likely to Have Surgery if Breast Cancer Diagnosed as an Emergency

6/8/2015 11:04 am

(Cancer Research UK) June 8, 2015 - Breast cancer patients are four times less likely to have potentially lifesaving surgery if diagnosed as an emergency rather than through an urgent GP referral, according to new data* published today (Monday).

Downsizing After Phase III Bust

6/3/2015 11:03 am

(European Biotechnology) June 2, 2015 - After disappointing Phase III results for immunotherapy tasquinimod and the subsequent discontinuation of the prostrate cancer drug, Swedish Active Biotech is now severely downsizing its operations.

Merck Extends Immuno-Oncology Collaboration with Agenus

6/3/2015 11:03 am

(MarketWatch) June 3, 2015 - Collaboration involves two proprietary Merck targets.

Perspective: Screening for Lung Cancer with Low-Dose CT — Translating Science into Medicare Coverage Policy

5/29/2015 03:00 pm

(NEJM) May 28, 2015 - Although low-dose computed tomography (CT) has been studied in several screening trials, the National Lung Screening Trial (NLST), sponsored by the National Cancer Institute, is the only trial to date that has shown that screening with low-dose CT reduces lung-cancer mortality.

Billionaire David Koch Pledges Record $150 Million For New Cancer Center

5/21/2015 12:03 pm

(Forbes) May 20, 2015 - David Koch, the 7th richest man in the world with a net worth of $42.7 billion, has pledged $150 million to Memorial Sloan Kettering to build a new outpatient cancer facility on Manhattan’s Upper East Side, the world-renowned cancer center announced Wednesday.

Puma Biotechnology Founder Auerbach Loses $250 Million on Cancer Drug Data

5/14/2015 01:05 pm

(Forbes) May 13, 2015 - On Wednesday afternoon, Forbes estimated Puma Biotechnology Founder, Chairman, and Chief Executive Alan Auerbach’s net worth at $1.19 billion.

Obamacare Program Generates 'Substantial' Medicare Savings

5/4/2015 11:02 am

(CNBC) May 4, 2015 - An Obamacare program designed to hold down Medicare costs and improve patient outcomes has generated more than $384 million in savings in its first two years of operation, Health and Human Services Secretary Sylvia Burwell said Monday.

Fast/Slow Telomere Shortening Predicts Cancer

5/1/2015 12:01 pm

(Genetic Engineering & Biotechnology News) May 1, 2015 - Telomere length hasn’t been a reliable yardstick for measuring the progress of cancer.

TESARO Announces Completion of Targeted Enrollment in Phase 3 NOVA Trial and Initiation of the QUADRA Trial of Niraparib

5/1/2015 12:01 pm

(CNNMoney) Apr 30, 2015 - TESARO, Inc., an oncology-focused biopharmaceutical company, today provided an update on its niraparib clinical development program.

Higher CVD Risks Reported for Hodgkin's Lymphoma Survivors

4/28/2015 12:00 pm

(Medscape Medical News) Apr 27, 2015 - Hodgkin's lymphoma (HL) is a curable disease with 10-year survival rates of greater than 80%. However, patients reaching adulthood show an increased incidence of cardiovascular disease (CVD) as a result of the therapy they received, and they are likely to turn to primary care physicians for treatment.

Angry Over Drug Prices, More States Push Bills for Pharma to Disclose Costs

4/24/2015 11:04 am

(Wall Street Journal/Pharmalot blog) Apr 24, 2015 - Should drug makers be required to disclose their costs to justify rising prices?

New Blood Test Shows Promise in Cancer Fight

4/20/2015 06:04 am

(New York Times) Apr 19, 2015 - In the usual cancer biopsy, a surgeon cuts out a piece of the patient’s tumor, but researchers in labs across the country are now testing a potentially transformative innovation.

NCCN Holds Fourth Annual State Oncology Society Forum

3/31/2015 12:01 pm

(NCCN) Mar 31, 2015 - The fourth annual state oncology society forum, held in conjunction with NCCN’s 20th Annual Conference, examined accountable care, payment reform, and best practices from community oncologists.

Obama Says He's Ready to Sign Fix of Medicare Doctor Payments, Without Endorsing Legislation

3/25/2015 12:04 pm

(U.S. News & World Report/Associated Press) Mar 25, 2015 - President Barack Obama said Wednesday that he's ready to sign good bipartisan legislation to fix Medicare's doctor payment problem, without endorsing any specific legislation.

Dietary Dioxins Don't Seem to Increase Breast Cancer Risk: Study

3/18/2015 11:04 am

(Drugs.com/HealthDay News) Mar 17, 2015 - Consuming low levels of chemicals called dioxins in food doesn't increase the risk of breast cancer, contends a new study that challenges a widely held belief about the effect of dioxins.

Study: Prices of Cancer Drugs Have Soared Since 1995

3/18/2015 11:04 am

(MIT News) Mar 18, 2015 - The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist — but the exact reasons for the cost increases are unclear.

Exact Sciences' Cologuard Gets Aetna Medicare Advantage Coverage

3/4/2015 12:03 pm

(GenomeWeb) Mar 4, 2015 - Exact Sciences today announced that Aetna will cover its Cologuard test under its Medicare Advantage plan, which serves 967,000 members across the country.